• 1
    Spiller R. Serotonergic drugs for functional gastrointestinal diseases. Br J Clin Pharmacol 2002; 54: 1120.
  • 2
    Mohammad S, Zhou Z, Gong Q, January CT. Blockage of the HERG human cardiac K+ channel by the gastrointestinal prokinetic agent cisapride. Am J Physiol 1997; 273: H2534H2538.
  • 3
    Drolet B, Khalifa M, Daleau P, Hamelin BA, Turgeon J. Block of the rapid component of the delayed rectifier potassium current by the prokinetic agent cisapride underlies drug-related lengthening of the QT interval. Circulation 1998; 97: 204210.
  • 4
    Tonini M, De Ponti F, Di Nucci A, Crema F. Review article: cardiac adverse effects of gastrointestinal prokinetics. Alim Pharmacol Ther 1999; 13: 15851591.
  • 5
    De Ponti F, Poluzzi E, Montanaro N. Organising evidence on QT prolongation and occurrence of torsades de pointes with non-antiarrhythmic drugs: a call for consensus. Eur J Clin Pharmacol 2001; 57: 185209.
  • 6
    Kaumann AJ, Sanders L. 5-Hydroxytryptamine causes rate-dependent arrhythmias through 5-HT4 receptor in human atrium: facilitation by chronic β–adrenoceptor blockade. Naunyn-Schmiedeberg Arch Pharmacol 1994; 349: 331337.
  • 7
    Kaumann AJ. Do human atrial 5-HT4 receptors mediate arrhythmias? Trends Pharmacol Sci 1994; 15: 451455.
  • 8
    Kaumann AJ, Lynham JA, Brown AM. Comparison of the densities of 5-HT4 receptors, β1- and β2-adrenoceptors in human atrium: functional implications. Naunyn-Schmiedeberg Arch Pharmacol 1996; 353: 592595.
  • 9
    Kii Y, Ito T. Effects of 5-HT4 receptor agonists, cisapride, mosapride citrate, and zacopride, on cardiac action potentials in guinea pig isolated papillary muscles. J Cardiovasc Pharmacol 1997; 29: 670675.
  • 10
    De Ponti F, Tonini M. Irritable bowel syndrome: new agents targeting serotonin receptor subtypes. Drugs 2001; 61: 317332.
  • 11
    Bridge MW, Marvin G, Thompson CE, Sharma A, Jones DA, Kendall MJ. Quantifying the 5-HT1A agonist action of buspirone in man. Psychopharmacology 2001; 158: 224229.
  • 12
    Alexander SPH, Mathie A, Peters JA. 5-Hydroxytryptamine receptors. Trends Pharmacol Sci 2001; 22 (Suppl): 6164.
  • 13
    Coulie B, Tack J, Maes B, Geypens B, De Roo M, Janssens J. Sumatriptan, a selective 5-HT1 receptor agonist, induces a lag phase for gastric emptying of liquids in humans. Am J Physiol 1997; 272: G902G908.
  • 14
    Tack J, Coulie B, Wilmer A, Andrioli A, Janssens J. Influence of sumatriptan on gastric fundus tone and on the perception of gastric distension in man. Gut 2000; 46: 468473.
  • 15
    Mawe GM, Branchek TA, Gershon MD. Peripheral neural serotonin receptors: identification and characterization with specific antagonists and agonists. Proc Natl Acad Sci USA 1986; 83: 97999803.
  • 16
    Crema F, Nardelli G, Moro E, De Ponti F, Frigo GM. Enhanced gastric accommodation by antimigraine triptans: role of 5-HT1B/D receptors. Pharmacol Res 2001; 43(Suppl A): 113.